'MK5172-059 A Phase II/III Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic HCV Infection with Advanced Cirrhosisand Child-Pugh (CP)-B Hepatic Insufficiency'